at CNBC.com (May 29, 2014)
KMG Chemicals (KMG +1.6%) trades up after its bottom line FQ3 number beat Street estimates earlier. Revenue missed however, as total sales decline by 10% Y/Y. Looking forward though, the companys expects its EPS to improve slightly in FQ4, citing around $1M in closing and integration costs which it anticipates recognizing for the improvement.
From other sites
at MarketWatch.com (Dec 7, 2012)
at MarketWatch.com (Oct 12, 2012)